Insiders · Profile

Rouan Sarah Kathryn

Director at Viking Therapeutics. Filing since 19 Jan 2024. CIK 0001761366

Company
Date
Role
Action
Shares
Amount
Of holding
31 Mar 2025
Director
Bought
1,240
$29.94K
opened
25 Oct 2024
Director
Sold on a plan
11,000
$889.79K
100%
8 Feb 2024
Director
Sold on a plan
25,000
$701.25K
100%
19 Jan 2024
Director
Sold on a plan
30,000
$691.50K
100%
4 decisions on file.